EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High ALG1 Expression Is Correlated With Poor Prognosis and the Immune Microenvironment in Glioma

Shuxiang Li iD, Yang Xia iD, Qiang Liu iD, Xin Qian iD, Anhong Liu iD, Jia Wang iD, Xinyu Wang iD, Di Zuo iD, Jing Zhang iD, Jinhai Ma iD, Peng Gao iD

Journal of Cellular and Molecular Medicine · 2026

DOI: 10.1111/jcmm.71142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2026. Verfasst von Shuxiang Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Province, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Glioma, Gene Expression Regulation, Neoplastic, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Natural Science Foundation of Ningxia, Scientific Research Program of Ningxia Colleges and Universities, Ningxia Medical University scientific research project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioma is the most prevalent primary tumour in the central nervous system. This study investigates ALG1 expression in glioma and its clinical significance. Using the TCGA and CGGA databases, a bioinformatics analysis examines ALG1 expression, its prognostic value, and its link to the immune microenvironment. Clinical samples are analysed using RT‐qPCR, Western blotting, and immunohistochemistry/fluorescence for expression validation. Single‐cell RNA sequencing (scRNA‐seq) assesses ALG1's role in cell state transitions. In vitro, wound healing assays are performed after ALG1 knockdown with siRNA, and in vivo analysis uses an in situ mouse model. The pan‐cancer analysis revealed that ALG1 is significantly overexpressed in varioustumours, including glioblastoma (GBM), and is linked to poor patient outcomes. A prognostic nomogram based on ALG1 levels accurately predicted 1‐, 3‐, and 5‐year survival rates for glioma patients. In clinical samples, ALG1 was highly expressed at both mRNA and protein levels, correlating with tumour grade. Single‐cell analysis showed increasing ALG1 expression from non‐tumorigenic to malignant states, especially in malignant cells. ALG1 overexpression altered tumour microenvironmentsignalling, changing IL10 and CYPA pathways associated with immune suppression. Knocking down ALG1 significantly reduced glioma cell migration and downregulated EMT‐related proteins like N‐cadherin, β‐catenin, and Vimentin. This study highlights ALG1 as a key prognostic biomarker and therapeutic target for glioma, promoting malignancy through increased cell migration, EMT modulation, and an altered immunosuppressive microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentGliomaGene Expression Regulation, NeoplasticBiomarkers, TumorBrain NeoplasmsCalcium-Binding ProteinsHumansPrognosisAnimalsCell Line, TumorMiceFemaleCell MovementEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

ALG1gliomaimmuneprognosistumour microenvironment

Substanzen

Biomarkers, TumorCalcium-Binding Proteins

Autor:innen und Institutionen

  • Department of Paediatrics, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Province, China.
  • Ningxia Key Laboratory of Cerebrocranial Diseases, Ningxia Medical University, Yinchuan, Ningxia Province, China.
  • Department of Neurosurgery, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Province, China.
  • The First People's Hospital of Shizuishan, Shizuishan, Ningxia Province, China.
  • Department of Nerve Electrophysiology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Province, China.
  • Institute of Medical Sciences, Reproductive Medicine Center, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Province, China.

ORCID-Profile: Shuxiang Li, Yang Xia, Qiang Liu, Xin Qian, Anhong Liu, Jia Wang, Xinyu Wang, Di Zuo, Jing Zhang, Jinhai Ma, Peng Gao

Förderung

  • the Natural Science Foundation of Ningxia
  • Scientific Research Program of Ningxia Colleges and Universities
  • Ningxia Medical University scientific research project
  • College Students' Innovative Entrepreneurial Training Plan Program
  • Natural Science Foundation of Ningxia Province

Zitieren

APA

Li, S., Xia, Y., Liu, Q., Qian, X., Liu, A., Wang, J., Wang, X., Zuo, D., Zhang, J., Ma, J., & Gao, P. (2026). High ALG1 Expression Is Correlated With Poor Prognosis and the Immune Microenvironment in Glioma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.71142

Vancouver

Li S, Xia Y, Liu Q, Qian X, Liu A, Wang J, et al. High ALG1 Expression Is Correlated With Poor Prognosis and the Immune Microenvironment in Glioma. Journal of Cellular and Molecular Medicine. 2026. doi:10.1111/jcmm.71142

BibTeX
@article{Li2026,
  author = {Li, Shuxiang and Xia, Yang and Liu, Qiang and Qian, Xin and Liu, Anhong and Wang, Jia and Wang, Xinyu and Zuo, Di and Zhang, Jing and Ma, Jinhai and Gao, Peng},
  title = {High ALG1 Expression Is Correlated With Poor Prognosis and the Immune Microenvironment in Glioma},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  doi = {10.1111/jcmm.71142}
}
Kostenlos starten →